Abnormal vaginal microbiome associated with vaginal mesh complications.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
11 2019
Historique:
received: 26 04 2019
accepted: 22 07 2019
pubmed: 14 8 2019
medline: 21 4 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

To identify differences in the vaginal microbiomes of women after transvaginal mesh (TVM) surgery for pelvic organ prolapse with and without mesh-associated complications. Patients with complications were eligible as cases, patients without as controls. DNA was isolated and the V1-2 region of the 16S ribosomal RNA gene was amplified and sequenced. Overall richness was quantified using Chao1. Overall diversity was expressed as Shannon diversity and screened for group differences using analysis of variance. Multivariate differences among groups were evaluated with functions from R. We recruited 14 patients after mesh exposure, 5 after contraction, and 21 as controls. The average number of operational taxonomic unit was 74.79 (SD ± 63.91) for controls, 57.13 (SD ± 58.74) after exposures, and 92.42 (SD ± 50.01) after contractions. Total 89.6% of bacteria in controls, 86.4% in previous exposures, and 81.3% in contractions were classified as either Firmicutes, Proteobacteria, or Actinobacteria (P < .001). Veillonella spp. was more abundant in patients after contraction (P = .045). The individual microbiomes varied, and we did not detect any significant differences in richness but a trend towards higher diversity with complications. The presence of Veillonella spp. could be associated with mesh contraction. Our study did not identify vaginal microbiotic dysbiosis as a factor associated with exposure. Larger cohort studies would be needed to distinguish the vaginal microbiome of women predisposed to mesh-related complications for targeted phenotyping of patients who could benefit from TVM surgery.

Identifiants

pubmed: 31402478
doi: 10.1002/nau.24129
pmc: PMC6852108
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2255-2263

Informations de copyright

© 2019 The Authors. Neurourology and Urodynamics published by Wiley Periodicals, Inc.

Références

Nat Rev Genet. 2011 Dec 16;13(1):47-58
pubmed: 22179717
BMC Genomics. 2012;13 Suppl 8:S17
pubmed: 23282177
Chem Biodivers. 2012 May;9(5):965-76
pubmed: 22589096
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Sci Transl Med. 2016 Aug 3;8(350):350ra102
pubmed: 27488896
Can J Microbiol. 2005 Sep;51(9):777-81
pubmed: 16391657
J Infect Dis. 2003 Oct 1;188(7):1054-8
pubmed: 14513427
Int Urogynecol J. 2017 Aug;28(8):1139-1151
pubmed: 28150032
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004014
pubmed: 23633316
Obstet Gynecol Surv. 2008 Apr;63(4):253-66
pubmed: 18348739
Lancet. 2017 Jan 28;389(10067):381-392
pubmed: 28010989
Neurourol Urodyn. 2019 Nov;38(8):2255-2263
pubmed: 31402478
Am J Obstet Gynecol. 2008 May;198(5):561.e1-4
pubmed: 18377864
Clin Lab Med. 2014 Dec;34(4):747-61
pubmed: 25439274
Eur Urol. 2018 Aug;74(2):167-176
pubmed: 29472143
ISME J. 2007 Jun;1(2):121-33
pubmed: 18043622
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Mar;19(3):437-40
pubmed: 17896064
Neurourol Urodyn. 2011 Jan;30(1):2-12
pubmed: 21181958
Front Physiol. 2015 Sep 29;6:253
pubmed: 26483694
Am J Obstet Gynecol. 2008 Dec;199(6):678.e1-4
pubmed: 18845282
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
J Gynecol Obstet Biol Reprod (Paris). 2013 Jun;42(4):334-41
pubmed: 23618743
Menopause. 2014 May;21(5):450-8
pubmed: 24080849
Int Urogynecol J. 2010 Mar;21(3):261-70
pubmed: 20052576
Int Urogynecol J. 2011 Jul;22(7):775-80
pubmed: 21512828
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):315-20
pubmed: 16228121
Mol Hum Reprod. 2009 Feb;15(2):131-7
pubmed: 19131402
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1749-56
pubmed: 24816815
Am J Obstet Gynecol. 2011 Jul;205(1):69.e1-8
pubmed: 21545996
FASEB J. 2013 Mar;27(3):1012-22
pubmed: 23165986

Auteurs

Nikolaus Veit-Rubin (N)

Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.

Renaud De Tayrac (R)

Department of Gynecology and Obstetrics, Caremeau University Hospital, Nîmes, France.

Rufus Cartwright (R)

Department of Urogynaecology, Oxford University Hospitals, Oxford, United Kingdom.

Larissa Franklin-Revill (L)

Department of Urogynaecology, St. Mary's Hospital, Imperial College London, London, United Kingdom.

Sophie Warembourg (S)

Department of Gynecology and Obstetrics, CHU La Croix-Rousse University Hospital Lyon, Lyon, France.

Catherine Dunyach-Remy (C)

Department of Microbiology, CHU Caremeau University Hospital, Montpellier University, Nîmes, France.

Jean-Philippe Lavigne (JP)

Department of Microbiology, CHU Caremeau University Hospital, Montpellier University, Nîmes, France.

Vik Khullar (V)

Department of Urogynaecology, St. Mary's Hospital, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH